Quality assurance/quality control (QA/QC) support
Active Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,171,969
Award facts
- Opportunity
-
- Resources to advance pediatrics and HIV prevention science Pre-Solicitation · 75N93021R00020 · Posted Feb 18, 2022
- Contract value 35% obligated
-
- $2,171,969.00 Current, with exercised options
- $6,169,389.00 Potential, with all options
- Completion date 50% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $569,390 | |
| Exercise an Option | $551,408 | |
| Exercise an Option | $534,007 | |
| Original award | $517,164 |
About this award
Advanced Bioscience Laboratories, Inc. (ABL) received a delivery order for Quality Assurance/Quality Control (QA/QC) support from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health. This cost-plus-fixed-fee contract, valued at $6.17 million with an ultimate completion date of April 14, 2030, will be performed in Rockville, Maryland. The award carries no small business set-aside designation, reflecting ABL's status as a large, foreign-owned biopharmaceutical research and manufacturing organization. This delivery order falls under the master Indefinite Delivery Vehicle (IDV) titled "Resources to Advance Pediatrics and HIV Prevention Science," a $98.9 million NIAID contract that provides ABL with a broad vehicle to deliver preclinical development support services across multiple disease areas and research initiatives.
ABL specializes in contract research and manufacturing services for gene therapies, vaccines, oncolytics, and immunotherapies, with particular expertise in biologics manufacturing, analytical testing, stability studies, and quality assurance. The company's existing work with NIAID and other NIH institutes—including the National Cancer Institute and National Institute of Neurological Disorders and Stroke—has focused on developing medical countermeasures for infectious diseases and supporting cGMP manufacturing and regulatory activities for vaccines and therapeutic biologics. The QA/QC support under this delivery order will contribute to NIAID's infectious disease research and product development mission, leveraging ABL's established capabilities in supporting preclinical and clinical development programs.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2023.
How much is contract 75N93023F00001 worth?
The government has obligated $2,171,969 on 75N93023F00001. Its potential value, with all options, is $6,169,389.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under 75N93023D00001, an indefinite delivery contract, on Resources to Advance Pediatrics and HIV Prevention Science.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award